Resectable Pancreatic Carcinoma

10 clinical trials · Condition

Record	Firm	Date
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation (NCT04858334)	National Cancer Institute (NCI)	2021-06-22
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery (NCT04560712)	M.D. Anderson Cancer Center	2020-08-12
Intravital Microscopy in Human Solid Tumors (NCT03823144)	Mayo Clinic	2019-02-28
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer (NCT03373188)	Emory University	2017-12-15
Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT02930902)	M.D. Anderson Cancer Center	2017-02-20
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT02427841)	OHSU Knight Cancer Institute	2016-01-21
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT02562716)	SWOG Cancer Research Network	2016-01-06
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer (NCT01959672)	University of Nebraska	2013-09-06
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma (NCT01333124)	National Cancer Center, Korea	2011-09-28

Track Resectable Pancreatic Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.